No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
SDGR250117C15000
- 4.95
- +0.05+1.02%
15min DelayClose Dec 24 13:00 ET
4.95High4.95Low
4.95Open4.90Pre Close1 Volume46 Open Interest15.00Strike Price495.00Turnover0.00%IV1.12%PremiumJan 17, 2025Expiry Date4.73Intrinsic Value100Multiplier24DDays to Expiry0.22Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.99Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
2024's 'Biggest Loses' That Could See Reversal in 2025
AI Driven Drug Discovery Patent Landscape Report 2024: 1,087 Patents Analyzed With Market Sales Data and Growth Rates - ResearchAndMarkets.com
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
Express News | Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)